Gefires 250mg Tablet
Marketer
Resonance Laboratories Pvt Ltd
Salt Composition
Gefitinib (250mg)
Overview Gefires 250mg Tablet
Afirme 250mg tablets treat advanced non-small cell lung cancer. This medication is for patients with metastatic disease, abnormal epidermal growth factor receptor (EGFR) genes, and no prior cancer therapy. Dosage and duration are determined by your physician. Regular liver function monitoring may be advised. Common side effects include nausea, diarrhea, dry skin, and appetite loss. Increased fluid intake may lessen side effects. Report any concerning or worsening side effects. Immediately report mouth sores, vision changes, or breathing problems. Women should use effective contraception during treatment and for one month afterward to prevent pregnancy. Disclose all other medications you are currently using to your doctor.
Uses of Gefires 250mg Tablet
Lung cancer (excluding small cell type)
Major Benefits of Gefires 250mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gefires 250mg Tablets can be consumed with or without food; however, consistent timing is recommended.
Common Side effects of Gefires 250mg Tablet:
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Vomiting
- Weakness
- Weight loss
- Eating disorder
- Allergic reaction
How to use Gefires 250mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gefires 250mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Gefires 250mg Tablet works:
Oncasin 250mg tablets are a cancer treatment that inhibits the activity of a faulty protein responsible for cancer cell proliferation, thus hindering or slowing tumor growth.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Gefires 250mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Gefires 250mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administering Gefires 250mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Gefires 250mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Gefires 250mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Gefires 250mg tablets in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary, though further information is limited. Physician consultation is advised.
What if you forget to take Gefires 250mg Tablet :
Omit any missed Gefires 250mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Gefires 250mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline amines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently